358 related articles for article (PubMed ID: 28672100)
1. Warfarin Pharmacogenomics in Diverse Populations.
Kaye JB; Schultz LE; Steiner HE; Kittles RA; Cavallari LH; Karnes JH
Pharmacotherapy; 2017 Sep; 37(9):1150-1163. PubMed ID: 28672100
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics of warfarin dosing in patients of African and European ancestry.
Shendre A; Dillon C; Limdi NA
Pharmacogenomics; 2018 Nov; 19(17):1357-1371. PubMed ID: 30345882
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics of warfarin: uncovering a piece of the warfarin mystery.
Gulseth MP; Grice GR; Dager WE
Am J Health Syst Pharm; 2009 Jan; 66(2):123-33. PubMed ID: 19139476
[TBL] [Abstract][Full Text] [Related]
4. Clinical applications of pharmacogenomics guided warfarin dosing.
Mahajan P; Meyer KS; Wall GC; Price HJ
Int J Clin Pharm; 2013 Jun; 35(3):359-68. PubMed ID: 21052837
[TBL] [Abstract][Full Text] [Related]
5. STRATEGIES FOR EQUITABLE PHARMACOGENOMIC-GUIDED WARFARIN DOSING AMONG EUROPEAN AND AFRICAN AMERICAN INDIVIDUALS IN A CLINICAL POPULATION.
Wiley LK; Vanhouten JP; Samuels DC; Aldrich MC; Roden DM; Peterson JF; Denny JC
Pac Symp Biocomput; 2017; 22():545-556. PubMed ID: 27897005
[TBL] [Abstract][Full Text] [Related]
6. Genotype-guided warfarin therapy: current status.
Tavares LC; Marcatto LR; Santos PCJL
Pharmacogenomics; 2018 May; 19(7):667-685. PubMed ID: 29701078
[TBL] [Abstract][Full Text] [Related]
7. Warfarin pharmacogenomics in African populations: the importance of ethnicity-based algorithms.
Jallul M; Alhudiri I; Al-Eitan L; Elzagheid A
Pharmacogenomics; 2022 Sep; 23(14):753-757. PubMed ID: 36004679
[TBL] [Abstract][Full Text] [Related]
8. Comparison of warfarin pharmacogenetic dosing algorithms in a racially diverse large cohort.
Shin J; Cao D
Pharmacogenomics; 2011 Jan; 12(1):125-34. PubMed ID: 21174627
[TBL] [Abstract][Full Text] [Related]
9. Clinical applications of pharmacogenomics guided warfarin dosing.
Mahajan P; Meyer KS; Wall GC; Price HJ
Int J Clin Pharm; 2011 Feb; 33(1):10-9. PubMed ID: 21365388
[TBL] [Abstract][Full Text] [Related]
10. Failure of pharmacogenetic-based dosing algorithms to identify older patients requiring low daily doses of warfarin.
Schwartz JB; Kane L; Moore K; Wu AH
J Am Med Dir Assoc; 2011 Nov; 12(9):633-8. PubMed ID: 21450231
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomics of warfarin in populations of African descent.
Suarez-Kurtz G; Botton MR
Br J Clin Pharmacol; 2013 Feb; 75(2):334-46. PubMed ID: 22676711
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a pharmacogenetic-based warfarin dosing algorithm in patients with low time in therapeutic range - study protocol for a randomized controlled trial.
Marcatto LR; Sacilotto L; Bueno CT; Facin M; Strunz CM; Darrieux FC; Scanavacca MI; Krieger JE; Pereira AC; Santos PC
BMC Cardiovasc Disord; 2016 Nov; 16(1):224. PubMed ID: 27855643
[TBL] [Abstract][Full Text] [Related]
13. Warfarin Pharmacogenomics for Precision Medicine in Real-Life Clinical Practice in Southern Africa: Harnessing 73 Variants in 29 Pharmacogenes.
Muyambo S; Ndadza A; Soko ND; Kruger B; Kadzirange G; Chimusa E; Masimirembwa CM; Ntsekhe M; Nhachi CFB; Dandara C
OMICS; 2022 Jan; 26(1):35-50. PubMed ID: 34958284
[TBL] [Abstract][Full Text] [Related]
14. Role of warfarin pharmacogenetic testing in clinical practice.
Tan GM; Wu E; Lam YY; Yan BP
Pharmacogenomics; 2010 Mar; 11(3):439-48. PubMed ID: 20402581
[TBL] [Abstract][Full Text] [Related]
15. Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design.
van Schie RM; Wadelius MI; Kamali F; Daly AK; Manolopoulos VG; de Boer A; Barallon R; Verhoef TI; Kirchheiner J; Haschke-Becher E; Briz M; Rosendaal FR; Redekop WK; Pirmohamed M; Maitland van der Zee AH
Pharmacogenomics; 2009 Oct; 10(10):1687-95. PubMed ID: 19842940
[TBL] [Abstract][Full Text] [Related]
16. Genotype-based dosing algorithms for warfarin therapy: data review and recommendations.
Johnson EG; Horne BD; Carlquist JF; Anderson JL
Mol Diagn Ther; 2011 Oct; 15(5):255-64. PubMed ID: 22047153
[TBL] [Abstract][Full Text] [Related]
17. Expanding role of pharmacogenomics in the management of cardiovascular disorders.
Yip VL; Pirmohamed M
Am J Cardiovasc Drugs; 2013 Jun; 13(3):151-62. PubMed ID: 23579966
[TBL] [Abstract][Full Text] [Related]
18. Clinical Model for Predicting Warfarin Sensitivity.
Ma Z; Cheng G; Wang P; Khalighi B; Khalighi K
Sci Rep; 2019 Sep; 9(1):12856. PubMed ID: 31492893
[TBL] [Abstract][Full Text] [Related]
19. Genetic testing before anticoagulation? A systematic review of pharmacogenetic dosing of warfarin.
Kangelaris KN; Bent S; Nussbaum RL; Garcia DA; Tice JA
J Gen Intern Med; 2009 May; 24(5):656-64. PubMed ID: 19306050
[TBL] [Abstract][Full Text] [Related]
20. Ethnic Diversity and Warfarin Pharmacogenomics.
Asiimwe IG; Pirmohamed M
Front Pharmacol; 2022; 13():866058. PubMed ID: 35444556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
